← Open Payments lookup

ANGELA RHOTEN: Open Payments

NPI 1841575230 · CLAREMORE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,046 in 68 payments from 12 companies in 2025. Trend: 2023 $540 · 2024 $775 · 2025 $1,046

Food & beverage: $1,046
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.33$410
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$213
Alkermes, Inc.5$89
Teva Pharmaceuticals USA, Inc.4$73
Janssen Pharmaceuticals, Inc4$69
ABBVIE INC.3$49
E.R. Squibb & Sons, L.L.C.2$43
Otsuka America Pharmaceutical, Inc.1$24
Vanda Pharmaceuticals Inc.1$22
Lundbeck LLC1$22

Products named: INGREZZA, CAPLYTA, ARISTADA, INVEGA SUSTENNA, UZEDY, VRAYLAR, COBENFY, ABILIFY MAINTENA.

Industry payments across OK — which companies pay providers there.